168 related articles for article (PubMed ID: 21416173)
21. Value of apparent diffusion coefficient for predicting malignancy of intraductal papillary mucinous neoplasms of the pancreas.
Zhang L; Rao SX; Xu XF; Wang DS; Jin da Y; Zeng MS
Diagn Interv Radiol; 2016; 22(4):308-13. PubMed ID: 27283593
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive intraductal papillary mucinous neoplasms and mucinous cystic neoplasms: recurrence rates and postoperative imaging follow-up.
Xourafas D; Tavakkoli A; Clancy TE; Ashley SW
Surgery; 2015 Mar; 157(3):473-83. PubMed ID: 25596773
[TBL] [Abstract][Full Text] [Related]
23. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of histological subtype in intraductal papillary mucinous neoplasm of the pancreas: A retrospective analysis of outcome from one single center.
Rong Y; Wang D; Xu C; Ji Y; Jin D; Wu W; Xu X; Kuang T; Lou W
Medicine (Baltimore); 2017 Apr; 96(15):e6599. PubMed ID: 28403101
[TBL] [Abstract][Full Text] [Related]
25. Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas.
Fritz S; Hackert T; Hinz U; Hartwig W; Büchler MW; Werner J
Br J Surg; 2011 Jan; 98(1):104-10. PubMed ID: 20949535
[TBL] [Abstract][Full Text] [Related]
26. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542
[TBL] [Abstract][Full Text] [Related]
27. Intraductal papillary mucinous neoplasms of the pancreas: radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines.
Strauss A; Birdsey M; Fritz S; Schwarz-Bundy BD; Bergmann F; Hackert T; Kauczor HU; Grenacher L; Klauss M
Br J Radiol; 2016; 89(1061):20150853. PubMed ID: 26959611
[TBL] [Abstract][Full Text] [Related]
28. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas.
Nagai K; Doi R; Ito T; Kida A; Koizumi M; Masui T; Kawaguchi Y; Ogawa K; Uemoto S
J Hepatobiliary Pancreat Surg; 2009; 16(3):353-8. PubMed ID: 19280108
[TBL] [Abstract][Full Text] [Related]
29. Validation of serum tumor biomarkers in predicting advanced cystic mucinous neoplasm of the pancreas.
Sun LQ; Peng LS; Guo JF; Jiang F; Cui F; Huang HJ; Jin ZD
World J Gastroenterol; 2021 Feb; 27(6):501-512. PubMed ID: 33642824
[TBL] [Abstract][Full Text] [Related]
30. Criteria for Determining Malignancy in Pancreatic Intraductal Papillary Mucinous Neoplasm Based on Computed Tomography.
Mönnings P; Belyaev O; Uhl W; Giese A; Tannapfel A; Köster O; Meier JJ
Digestion; 2016; 94(4):230-239. PubMed ID: 28030856
[TBL] [Abstract][Full Text] [Related]
31. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.
Marchegiani G; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
J Am Coll Surg; 2015 May; 220(5):839-44. PubMed ID: 25840549
[TBL] [Abstract][Full Text] [Related]
32. Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Moris D; Damaskos C; Spartalis E; Papalampros A; Vernadakis S; Dimitroulis D; Griniatsos J; Felekouras E; Nikiteas N
Anticancer Res; 2017 May; 37(5):2185-2194. PubMed ID: 28476781
[TBL] [Abstract][Full Text] [Related]
33. Can contrast-enhanced harmonic endoscopic ultrasonography accurately diagnose main pancreatic duct involvement in intraductal papillary mucinous neoplasms?
Ohno E; Kawashima H; Ishikawa T; Iida T; Suzuki H; Uetsuki K; Yashika J; Yamada K; Yoshikawa M; Gibo N; Aoki T; Kataoka K; Mori H; Hirooka Y; Fujishiro M
Pancreatology; 2020 Jul; 20(5):887-894. PubMed ID: 32651080
[TBL] [Abstract][Full Text] [Related]
34. Intraductal papillary mucinous neoplasms of the pancreas (IPMNs): epidemiology, diagnosis and future aspects.
Konstantinou F; Syrigos KN; Saif MW
JOP; 2013 Mar; 14(2):141-4. PubMed ID: 23474557
[TBL] [Abstract][Full Text] [Related]
35. Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Permuth-Wey J; Chen DT; Fulp WJ; Yoder SJ; Zhang Y; Georgeades C; Husain K; Centeno BA; Magliocco AM; Coppola D; Malafa M
Cancer Prev Res (Phila); 2015 Sep; 8(9):826-34. PubMed ID: 26314797
[TBL] [Abstract][Full Text] [Related]
36. Value of diffusion-weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas.
Jang KM; Kim SH; Min JH; Lee SJ; Kang TW; Lim S; Choi D
AJR Am J Roentgenol; 2014 Nov; 203(5):992-1000. PubMed ID: 25341136
[TBL] [Abstract][Full Text] [Related]
37. Pre-operative nomogram predicting malignant potential in the patients with intraductal papillary mucinous neoplasm of the pancreas: focused on imaging features based on revised international guideline.
Hwang JA; Choi SY; Lee JE; Kim SS; Lee S; Moon JY; Heo NH
Eur Radiol; 2020 Jul; 30(7):3711-3722. PubMed ID: 32095876
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of Deep Learning Analysis for the Diagnosis of Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Kuwahara T; Hara K; Mizuno N; Okuno N; Matsumoto S; Obata M; Kurita Y; Koda H; Toriyama K; Onishi S; Ishihara M; Tanaka T; Tajika M; Niwa Y
Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31117111
[TBL] [Abstract][Full Text] [Related]
39. Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas.
Pedrazzoli S; Sperti C; Pasquali C; Bissoli S; Chierichetti F
Ann Surg; 2011 Dec; 254(6):971-6. PubMed ID: 22076067
[TBL] [Abstract][Full Text] [Related]
40. Low high-density lipoprotein cholesterol levels are associated with malignant intraductal papillary mucinous neoplasms: A multicenter study.
Wang C; Lin T; Wang X; Yu Z; Zhuge X; Cui W; Wang M; Wang Z; Guo C; Chen X
Lipids Health Dis; 2021 Aug; 20(1):94. PubMed ID: 34454509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]